Oxford Biomedica (OXB) Health Care Sector

Latest Quote Price

Price Change (%)

Trading Velocity

Activity Score

Momentum Score

Consensus Score


Latest Bid : Latest Ask :
High Today : Low Today :
This Years High : This Years Low :
Volume : MKT Cap :

Stock Splits and Consolidations

30/05/2018 – Stock Consolidation 50.000:1.000


Oxford Biomedica Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

Latest Oxford Biomedica Tips

Type Tipster SectorScore Start date Performance
Alan Oscroft 2021-10-26 14:05:00 26/10/2021
Peel Hunt 2021-10-19 16:46:00 19/10/2021
Liberum Capital 2021-09-30 07:41:00 30/09/2021
Jefferies 2021-09-28 04:47:00 28/09/2021
Emma Powell 2021-09-23 07:35:00 23/09/2021

Oxford Biomedica Data Charts

Premium Charts

Latest Bid : Latest Ask :
High Today : Low Today :
This Years High : This Years Low :
Volume : MKT Cap :

Oxford Biomedica Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

Latest Oxford Biomedica Tips

Type Tipster SectorScore Start date Performance
Alan Oscroft 2021-10-26 14:05:00 26/10/2021
Peel Hunt 2021-10-19 16:46:00 19/10/2021
Liberum Capital 2021-09-30 07:41:00 30/09/2021
Jefferies 2021-09-28 04:47:00 28/09/2021
Emma Powell 2021-09-23 07:35:00 23/09/2021

Stock Splits and Consolidations

30/05/2018 – Stock Consolidation 50.000:1.000